A cluster heatmap confirmed that SCLC CM treatment upregulated the expression of NOTCH1 and several canonical ligands and downstream genes, including DLL1/4, JAG2, target genes HES1/5, HEY2, and transcription factor RBPJL (Fig. 4C). This evidence concerns the gene HEY2 and small cell lung carcinoma.